ESC Premium Access

Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)

Congress Presentation

About the speaker

Doctor Ulrich Fischer-Rasokat

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)
0 follower

4 more presentations in this session

State of the Art: TAVI indications and adoption: a dynamic field

Speaker: Professor B. Prendergast (London, GB)


Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.

Speaker: Professor E. Durand (Rouen, FR)


Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

Speaker: Doctor B. Alushi (Munich, DE)


TAVI complications: incidence, trends and management.

Speaker: Professor A. Chieffo (Milan, IT)


Access the full session

TAVI: a new standard for aortic valve replacement?

Speakers: Doctor U. Fischer-Rasokat, Professor B. Prendergast, Professor E. Durand, Doctor B. Alushi, Professor A. Chieffo

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb